Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quintiles To Help Launch Pharmaxis CF Drug | Contract Pharma
Breaking News, Collaborations & Alliances

Quintiles To Help Launch Pharmaxis CF Drug

Bronchitol expected to launch in EU in 2011

Quintiles has signed an agreement with Pharmaxis to provide a broad range of commercial solutions to support the European launch of Bronchitol, an innovative treatment for cystic fibrosis.
Quintiles will execute a comprehensive commercialization effort for Bronchitol across western Europe. Beginning with Germany in early 2011, Quintiles will later support the commercialization of Bronchitol in France, Spain, Italy, Austria, Switzerland, the Netherlands, Belgium, Luxemburg and Portugal. Quintiles’ services include development of the overall market access strategy, pricing and reimbursement, local market access, product management, and recruitment and management of field-based commercial teams.
Designed to reduce the amount of mucus build-up in the lungs of patients suffering from chronic respiratory conditions, Bronchitol was awarded orphan drug designation for cystic fibrosis in the EU and U.S. Pharmaxis anticipates approval for the product in Europe by the close of 2010, with promotional activities beginning in 2011.
“Bronchitol is an important advancement in the treatment of cystic fibrosis,” said Gary Phillips, acting chief executive officer, Pharmaxis. “To get this critical therapy to patients, we need the right partner to ensure our market entry goes smoothly. Europe is a complex area in which to launch a product, and Quintiles’ experience, breadth and expertise in the region made them the ally of choice. They are experts at market access, field sales and product promotion, and understand the nature of the region.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters